Oncology Digital Health: Evidence Requirements from Payers and Regulatory Bodies

The marriage of digital health and oncology is very new, with companies still figuring out the best approach to establish in the market. For entrepreneurs, it is important to have as many options as possible, which makes clinical and economic evidence critical for most solutions to ease adoption. This requires a nuanced understanding of what the evidence standards are for different stakeholders. In this meeting, we will focus on payers and regulatory bodies.